人参口服液对原发性肝癌放疗和化疗副作用的防治  

Ginseng alleviation of adverse effects from radiotherapy or chemother apy in liver cancer patients

作　　者：程琳[1] 

机构地区：[1]上海医科大学附属肿瘤医院,上海200032

出　　处：《新药与临床》1989年第2期65-66,共2页

摘　　要：对原发性肝癌放疗或化疗的41名患者,采用随机方法,设有治疗组(服人参口服液)21人,对照组(服糖水)20人。结果表明,人参口服液对肝癌放疗和化疗的副作用有明显改善作用,有效率86％,能使患者的一般情祝、症状和肝功能得到改善,并具有升高外周血白细胞的功效,与对照组相比,有明显统计学意义,但无明显降低甲胎蛋白的作用。41 patients with primary liver cancer(PLC) submitted to radiotherapy or chemotherapy were divided into two groups at random. 21 of them received per os the infusion of solid Chinese Jilin white ginseng 250 mg twice a day for 30 days as a course concomitant with the main therapy, while the other 20 patients, placebo of sugar solution. 1 or 2 courses were given as a rule. Ginseng was definitely beneficial to those side effects developing during the radiotherapy or chemotherapy. In general, the physical condition, nausea, vomiting, abdominal pain, hepatic function and white count were improved. The effective rate was 85%, while the placebo 20% only (P<0.01). No significant reduction of serum alpha fetopro-tein was noted.

关 键 词：人参 肝肿瘤 药物疗法 

分 类 号：R735.705[医药卫生—肿瘤]